← Back to headlines
Immunome's Chief Scientist Trims Stake Ahead of Planned FDA Submission
Immunome's Chief Scientist has reduced his stake in the company, a move that comes ahead of a planned FDA submission, suggesting potential implications for the company's future.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
